Released Jun 14, 2011, after the close
10-Q filed Jun 14, 2011, 45 days after period end · 0001144204-11-035716
Q2 2011 · 10-Q
Revenue—
Net Income$479.69K$479.69K no prior Q2 2010 on file+34.6% vs Q1 2011
EPS Diluted$0.02$0.02 no prior Q2 2010 on file+31.3% vs Q1 2011
Gross Profit$1,545,000—
Operating Income$736,755—
Operating Cash Flow$187,027—
Free Cash Flowderived$130,877—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q2 2010 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pharma-Bio Serv, Inc. · CIK 1304161 · Engraved from SEC EDGAR